CSIMarket
 


Oramed Pharmaceuticals Inc   (ORMP)
Other Ticker:  
 

Oramed Pharmaceuticals Inc 's Leverage Ratio

ORMP's quarterly Leverage Ratio and Total Liabilities, Equity growth




ORMP Leverage Ratio (Feb 29 2020)
II. Quarter
(Nov 30 2019)
I. Quarter
(Aug 31 2019)
IV. Quarter
(May 31 2019)
III. Quarter
(Feb 28 2019)
II. Quarter
Y / Y Equity Change -36.52 % -40.54 % -37.67 % 29.42 % 23.77 %
Y / Y Total Liabilities Change 399.89 % 314.83 % -6.23 % -84.26 % -84.59 %
Leverage Ratio MRQ 0.85 0.81 0.79 0.13 0.11
Overall Ranking # # # # #
Seq. Equity Change -6.24 % -11.51 % -10.04 % -14.96 % -12.16 %
Seq. Total Liabilities Change -1.33 % -9.13 % 439 % 3.43 % -18.12 %



Leverage Ratio second quarter 2020 Comment
Despite repayements of liabilities of -1.33%, in II. Quarter ,Leverage Ratio detoriated to 0.85, above company's average Leverage Ratio.

Within Major Pharmaceutical Preparations industry in the second quarter 2020 only one company achieved lower Leverage Ratio than Oramed Pharmaceuticals Inc . While total ranking remained unchanged compare to previous quarter at no. .

Explain Leverage Ratio?
Who are ORMP Customers?
Leverage Ratio second quarter 2020 Company Ranking
Within: No.
Major Pharmaceutical Preparations Industry # 2
Healthcare Sector # 8
Overall Market # 72


Leverage Ratio Statistics
High Average Low
1.08 0.38 0.02
(May 31 2018)   (Feb 28 2014)




Financial Statements
Oramed Pharmaceuticals Inc 's Equity $ 16 Millions Visit ORMP's Balance sheet
Oramed Pharmaceuticals Inc 's Total Liabilities $ 14 Millions Visit ORMP's Balance sheet
Source of ORMP's Sales Visit ORMP's Sales by Geography




Companies with similar Leverage Ratio in the quarter endingFeb 29 2020, within Major Pharmaceutical Preparations Industry Leverage RatioFeb 29 2020 MRQ Total LiabilitiesFeb 29 2020 MRQ Equity
Chemocentryx Inc   2.28 $ 137.141  Millions$ 60.161  Millions
Insmed Inc  2.27 $ 469.824  Millions$ 206.701  Millions
Fortress Biotech Inc   2.23 $ 167.884  Millions$ 75.285  Millions
Lipocine Inc   2.20 $ 14.439  Millions$ 6.553  Millions
Progenics Pharmaceuticals Inc  2.19 $ 67.115  Millions$ 30.613  Millions
Dare Bioscience Inc   2.18 $ 7.000  Millions$ 3.214  Millions
Merck and Co Inc   2.16 $ 56,765.000  Millions$ 26,300.000  Millions
Harrow Health Inc   2.10 $ 31.556  Millions$ 15.028  Millions
Prestige Consumer Healthcare Inc   2.00 $ 2,342.934  Millions$ 1,170.971  Millions
Ptc Therapeutics inc   1.92 $ 1,016.858  Millions$ 528.734  Millions
Reata Pharmaceuticals Inc   1.90 $ 435.550  Millions$ 228.647  Millions
Corbus Pharmaceuticals Holdings Inc   1.87 $ 42.512  Millions$ 22.691  Millions
Amag Pharmaceuticals inc   1.86 $ 489.837  Millions$ 263.738  Millions
Chembio Diagnostics Inc   1.82 $ 33.059  Millions$ 18.133  Millions
China Pharma Holdings Inc   1.67 $ 14.031  Millions$ 8.380  Millions
Contrafect Corp  1.63 $ 13.995  Millions$ 8.609  Millions
Assertio Therapeutics inc   1.61 $ 135.237  Millions$ 84.037  Millions
Bristol Myers Squibb Co  1.59 $ 79,374.000  Millions$ 49,977.000  Millions
Biodelivery Sciences International Inc   1.57 $ 120.028  Millions$ 76.588  Millions
Mylan N v   1.54 $ 17,345.000  Millions$ 11,262.700  Millions
Titan Pharmaceuticals Inc  1.51 $ 7.986  Millions$ 5.276  Millions
Sarepta Therapeutics Inc   1.49 $ 1,711.487  Millions$ 1,144.828  Millions
Pfizer Inc  1.47 $ 96,042.000  Millions$ 65,338.000  Millions
Ani Pharmaceuticals Inc  1.40 $ 281.061  Millions$ 201.171  Millions
Regulus Therapeutics Inc   1.35 $ 20.104  Millions$ 14.902  Millions
Fitlife Brands Inc   1.34 $ 6.306  Millions$ 4.698  Millions
Johnson and Johnson  1.34 $ 82,115.000  Millions$ 61,294.000  Millions
Celsion Corp  1.34 $ 21.688  Millions$ 16.209  Millions
Menlo Therapeutics Inc   1.31 $ 90.998  Millions$ 69.535  Millions
Clearside Biomedical Inc   1.28 $ 13.408  Millions$ 10.440  Millions


       
Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

BKGM's Profile

Stock Price

BKGM's Financials

Business Description

Fundamentals

Charts & Quotes

BKGM's News

Suppliers

BKGM's Competitors

Customers & Markets

Economic Indicators

BKGM's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Indices

Sectors & Industries

Financials

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.  Free Stock Market News Feeds
   Copyright © 2020 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

To view Intraday Stock Data Java must be installed. Java content may be prohibited by the security software, to see the stock quotes, choose "allow content from this page" option. Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071